Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

STRYKER CORPORATION

(SYK)
  Report
Real-time Estimate Cboe BZX  -  11:36 2022-12-02 am EST
240.75 USD   -0.01%
09:35aBarclays Adjusts Price Target on Stryker to $257 From $239, Maintains Overweight Rating
MT
11/15Stryker Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
11/14Stryker opens the OR of the Future for customers to experience tomorrow's OR today
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting

09/14/2022 | 08:06am EST

The Company Will Also Debut its Prophecy Footprint and Expanded Offerings

Stryker (NYSE:SYK) today announced the launch of its Pulse Intelligent Delivery Platform, a full-circle product and fulfillment offering optimized for high volume foot and ankle procedures in the ambulatory surgery center (ASC) setting, which will debut at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting (AOFAS), taking place Sept. 14-17 in Québec City, Canada. The company will also feature its Prophecy® Footprint Surgical Planning, which will be the first surgical planning tool to provide clinical guidance on the whole foot in connection with total ankle arthroplasty.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220914005257/en/

Stryker's Pulse Intelligent Delivery Platform provides an integrated product configuration and delivery offering for foot and ankle surgery within the ASC setting of care through smarter configurations, personalized inventory, and automated service. (Graphic: Business Wire)

Stryker's Pulse Intelligent Delivery Platform provides an integrated product configuration and delivery offering for foot and ankle surgery within the ASC setting of care through smarter configurations, personalized inventory, and automated service. (Graphic: Business Wire)

“This is an exciting year for Stryker’s Foot & Ankle business, as we continue to expand our robust portfolio to meet the needs of our surgeon customers,” said Michael Rankin, VP Marketing and Medical Education, Stryker’s Foot & Ankle business unit. “With the launch of the Pulse Intelligent Delivery Platform, we now offer a comprehensive suite of products that provides a robust program for foot and ankle surgery within an ASC setting.”

The Pulse Intelligent Delivery Platform provides an integrated product configuration and delivery offering for foot and ankle surgery within the ASC setting of care through:

  • Smarter Configurations: Pulse offers a comprehensive suite of surgery-ready forefoot products designed to reduce clutter in the operating room as well as provide ease of use, sterilization processing cost savings and sustainability.
  • Personalized Inventory: Pulse’s procedure mapping technology learns from customer preferences and makes inventory recommendations to keep facilities stocked with what they need.
  • Automated Service: Radio frequency identification (RFID) technology monitors ASC inventory and triggers replenishment orders automatically, providing peace of mind to ASC stakeholders and surgeons alike.

"As surgical procedures continue to migrate to the ASC setting, both surgeons and administrators are looking for ways to streamline their operational efficiency while increasing the reliability of their surgical equipment,” said Bruce Cohen, MD, CEO of OrthoCarolina. “Efficiency and reliability are exactly what Stryker’s Pulse platform provides for forefoot procedures in the ASC."

Other Products Debuting at AOFAS

Also being introduced at AOFAS is Prophecy Footprint, an add-on service to Stryker’s Prophecy Surgical Planning system that provides an understanding of the ancillary procedures to be considered for patients needing total ankle replacement surgery with concomitant pathology. Prophecy Footprint is currently in limited release in the U.S., with plans for a full launch next year.

“We also look forward to introducing Prophecy Footprint at AOFAS, which will change the way surgeons prepare and plan for total ankle cases,” said Rankin. “In order to have a successful total ankle surgery, you have to consider what is going on with the foot itself. By facilitating a more comprehensive view of the foot around the ankle, Footprint can help surgeons with their most complex patient populations.”

Rounding out its offering for foot and ankle procedures, Stryker will showcase the CurveBeam AI HiRise weight-bearing computerized tomography (WBCT) imaging system at AOFAS. Stryker’s Foot & Ankle business has entered into an exclusive co-promotion and distribution agreement with CurveBeam AI, a leader in WBCT. This exclusive agreement will offer a turnkey surgical solution for our foot and ankle surgeon customers treating complex deformities.

Stryker will offer product demonstrations and a virtual reality experience at AOFAS at booth #103 for more information.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.


ę Business Wire 2022
All news about STRYKER CORPORATION
09:35aBarclays Adjusts Price Target on Stryker to $257 From $239, Maintains Overweight Rating
MT
11/15Stryker Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial ..
AQ
11/14Stryker opens the OR of the Future for customers to experience tomorrow's OR today
PR
11/14Stryker Opens the OR of the Future for Customers to Experience Tomorrow's OR
CI
11/04Insider Sell: Stryker
MT
11/03Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
GL
11/02DA Davidson Adjusts Stryker Price Target to $250 From $260, Maintains Buy Rating
MT
11/01Uber, Pfizer rise; Catalent, Stryker fall
AQ
11/01STRYKER CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
11/01"Risk-on" activated
MS
More news
Analyst Recommendations on STRYKER CORPORATION
More recommendations
Financials (USD)
Sales 2022 18 200 M - -
Net income 2022 2 568 M - -
Net Debt 2022 10 483 M - -
P/E ratio 2022 33,6x
Yield 2022 1,19%
Capitalization 88 511 M 88 511 M -
EV / Sales 2022 5,44x
EV / Sales 2023 5,05x
Nbr of Employees 46 000
Free-Float 98,2%
Chart STRYKER CORPORATION
Duration : Period :
Stryker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRYKER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Last Close Price 233,89 $
Average target price 236,37 $
Spread / Average Target 1,06%
EPS Revisions
Managers and Directors
Kevin A. Lobo Chairman, President & Chief Executive Officer
Glenn S. Boehnlein Chief Financial Officer & Vice President
Alan Douville Chief Information Officer & Vice President
Dana S. McMahon Chief Compliance Officer & Vice President
Howard E. Cox Director-Emeritus
Sector and Competitors
1st jan.Capi. (M$)
STRYKER CORPORATION-9.97%88 511
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.-10.54%14 649
SMITH & NEPHEW PLC-16.62%11 263
INSPIRE MEDICAL SYSTEMS, INC.4.18%6 980
AXONICS, INC.26.55%3 392
ENOVIS CORPORATION-28.53%2 931